WHO initiated the series of "International Meeting of the World Pharmacopoeias (IMWP)" meetings in 2012. The IMWP brings together national and regional pharmacopoeias and brings forward initiatives to strengthen their cooperation to improve public health outcomes. The IMWP is an ideal platform to emphasize the role and importance of quality aspects when speaking about access to medicines worldwide. Pharmacopoeias set quality standards for manufacturers to produce medicines and vaccines which are safe and of good quality. Regulators ensure that manufacturers comply with these quality standards before medicines are authorized to be on the market and throughout the product's shelf life.
WHO / Christopher Black
WHO headquarters in Geneva, Switzerland. Statue commemorating the 30th anniversary of the eradication of smallpox.
WHO headquarters in Geneva, Switzerland. Statue commemorating the 30th anniversary of the eradication of smallpox.
©
Credits